Resolution of thrombotic thrombocytopenic purpura serous retinal detachment following rituximab therapy.
Serous retinal detachment should be considered in cases of acute painless visual loss in patients with TTP. Prompt escalation of immunotherapy, particularly rituximab, seems to safeguard excellent visual and anatomical outcomes.
Authors
- Marta Guedes (ORCID: https://orcid.org/0000-0001-5442-5571)
- M. R. S. Correia (ORCID: https://orcid.org/0000-0001-5428-2822)
- Maria Madeira (ORCID: https://orcid.org/0009-0009-2756-9145)
- João Rodrigues Caeiro Acabado Romana
Institutions
- Hospital de Egas Moniz (PT)
- Águas de Portugal (Portugal) (PT)
Publication Details
- Journal
- Retinal Cases & Brief Reports
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1097/icb.0000000000001821
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00